Profile
THMO ABT BSX-PA BSX SYK MDT
Company Name ThermoGenesis Holdings, Inc. Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $1.59K $220.36B $175.45B $149.61B $146.70B $119.58B
Employees 0.03K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Xiaochun Xu Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
THMO ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 1 3 3
Quant Rating Sell Buy Strong Sell Neutral Neutral
Trading
THMO ABT BSX-PA BSX SYK MDT
Last Close $0.0001 $126.61 $122.18 $100.97 $375.93 $93.23
High 52 - $140.22 $122.18 $108.14 $403.53 $98.43
Low 52 - $111.1 $122.18 $83.62 $337.28 $79.61
Price vs. 52 Week High 0 % -9.71 % 0 % -6.63 % -6.84 % -5.28 %
Price vs. 52 Week Low 0 % 13.96 % 0 % 20.75 % 11.46 % 17.11 %
Total Return
THMO ABT BSX-PA BSX SYK MDT
1 Month Return 0 % -4.88 % 0 % 4.05 % 1.64 % -0.79 %
3 Month Return 0 % -1.09 % 0 % -5.17 % -6.15 % 0.85 %
6 Month Return 0 % -2.98 % 0 % -1.72 % 1.33 % 10.2 %
9 Month Return -85.71 % -0.98 % 0 % -1.69 % -3.87 % 1.99 %
YTD Return -85.71 % 11.94 % 0 % 13.04 % 4.41 % 16.71 %
1 Year Return -83.33 % 11.65 % 0 % 19.41 % 4.71 % 3.22 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
THMO ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.86 % - - 0.88 % 3.02 %
Dividend Paid and Capex Coverage Ration (TTM) -2.15 % 1.45 % 4.3 % 4.3 % 2.39 % 1.31 %
Dividend Per Share (TTM) - 2.36 % - - 3.36 % 2.82 %
Payout Ratio (TTM) - 28.42 % 0.92 % 0.82 % 42.87 % 77.26 %
Growth
THMO ABT BSX-PA BSX SYK MDT
Asset Growth -42.06 % 11.2 % 12.12 % 12.12 % 1.89 %
Gross Profit Growth -28.75 % 6.43 % 16.26 % 16.26 % 3.58 %
Revenue Growth -9.9 % 4.59 % 17.61 % 17.61 % 3.62 %
Revenue 3 Year -94.29 % -0.18 % 36.16 % 36.16 % 10.52 %
Revenue 5 Year -98.31 % 34.24 % 47.52 % 47.52 % 20.96 %
Revenue 10 Year -99.93 % 80.43 % 104.22 % 104.22 % 41.05 %
EBIT Growth -43.43 % 3.45 % 18.25 % 18.25 % 14.42 %
Net Income Growth -59.49 % 134.18 % 16.38 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share 93.52 % 94.27 % 72.31 % 72.31 % -3.39 %
Net Income 5 Yeari Growth Per Share 99.22 % 271.11 % -62.7 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share 99.76 % 410.99 % 1502.13 % 1502.13 % 48.51 %
Operating Income Growth -39.03 % 6.06 % 20.82 % 20.82 % 15.77 %
Operating Cash Flow Growth (CFG) 48.91 % 17.86 % 37.24 % 37.24 % 3.79 %
Operating 3 Year CFG 98.48 % -16.72 % 77.55 % 77.55 % 0.13 %
Operating 5 Year CFG 99.08 % 42.4 % 76.92 % 76.92 % 1.55 %
Operating 10 Year CFG 99.95 % 102.79 % 143.61 % 143.61 % 22.45 %
EPS Growth 62.89 % 132.42 % 16.61 % 16.61 % 31.05 %
EPS Diluted Growth 62.89 % 133.64 % 16.52 % 16.52 % 30.8 %
Book Value Per Share -125.09 % 23.54 % 11.25 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share -101.69 % 36.46 % 26.58 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share -100.34 % 56.53 % 48.35 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share -100 % 92.83 % 186.31 % 186.31 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % -100 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - - 128.74 %
Debt Growth 1.84 % -3.77 % 17.44 % 17.44 % 13.95 %
Free Cash Flow Growth 29.01 % 25.54 % 55.31 % 55.31 % -0.29 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2024 31 Dec 2024 25 Apr 2025
Profitability
THMO ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 20.44 % 52.79 % 63.23 % 65.05 % 62.19 % 63.44 %
Return on Assets TTM -160.03 % 16.64 % 6.02 % 6.71 % 6.3 % 5.12 %
Return on Equity TTM -1367.44 % 29.93 % 11.49 % 12.8 % 14.08 % 9.62 %
Return on Capital Employed TTM 1240.38 % 10.7 % 8.19 % 9.22 % 13.86 % 7.71 %
Net Income Per EBT TTM 95.01 % 176.99 % 83.43 % 85.26 % 87.08 % 82.32 %
EBT Per Ebit TTM 287.79 % 104.64 % 100.71 % 97.5 % 61.93 % 92.49 %
EBIT Per Revenue TTM -69.6 % 17.51 % 16.1 % 17.33 % 22.72 % 17.9 %
Cash Flow To Debt Ratio TTM -35.25 % 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Receivables Turnover TTM 9.95 4.21 6.57 6.87 6.08 5.46
Payables Turnover TTM 7.93 4.73 7.07 7.03 6.25 4.89
Inventory Turnover TTM 5.34 2.93 2.38 2.36 1.7 -33.52
Fixed Asset Turnover TTM 162.96 % 378.32 % 467.97 % 489.63 % 560.03 % -6785.71 %
Asset Turnover TTM 84.09 % 51.32 % 44.5 % 46.56 % 51.41 % 37.59 %
Operating Cash Flow Per Share TTM -1.57 5.19 2.9 2.89 12.47 5.58
Free Cash Flow Per Share TTM -2.3 3.89 2.24 2.23 10.53 4.14
Cash Per Share TTM 84.46 % 418.4 % 36.12 % 36.04 % 644.69 % 633.66 %
Operating Cash Flow Sales Ratio TTM -39.4 % 20.96 % 23.17 % 22.14 % 20.01 % 20.89 %
Free Cash Flow Operating Cash Flow Ratio TTM 146.57 % 74.97 % 77.27 % 77.27 % 84.43 % 74.21 %
Cash Flow Coverage Ratios TTM -35.25 % 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Price To Free Cash Flows Ratio TTM - 32.53 45.25 45.19 36.46 22.55
Price To Operating Cash Flows Ratio TTM - 24.38 34.89 34.91 30.77 16.72
Price Cash Flow Ratio TTM - 24.38 34.89 34.91 30.77 16.72
Income Statement (TTM)
THMO ABT BSX-PA BSX SYK MDT
Revenue $0.01B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $0B $21.33B $10.27B $10.27B $13.98B $21.91B
Gross Profit Ratio 20.44% 50.83% 61.31% 61.31% 61.87% 65.32%
EBITDA $-0.01B $10.83B $3.94B $3.94B $4.94B $9.22B
Net Income $-0.02B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -7.59 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
THMO ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $9.37B $9.37B $12.57B $25.64B
Total Liabilities $0.01B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $-0B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.88B $6.75B
Total Debt $0.01B $15.28B $11.15B $11.15B $14.12B $28.52B
Total Assets $0.01B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
THMO ABT BSX-PA BSX SYK MDT
Net Income $-0.02B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.23B $-0.21B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 124.485
ADGM Adagio Medical Holdings, Inc. 1.21
AEMD Aethlon Medical, Inc. 5.78
AFIB Acutus Medical, Inc. 0.0003
AHCO AdaptHealth Corp. 9.155
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 132.04
ALUR Allurion Technologies Inc. 1.83
AMIX Autonomix Medical, Inc. Common Stock 1.05
ANIK Anika Therapeutics, Inc. 9.7
AORT Artivion, Inc. 44.99
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.95
ARAY Accuray Incorporated 1.445
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 16.49
AVNS Avanos Medical, Inc. 11.41
AVR Anteris Technologies Global Corp. Common Stock 4.41
AXDX Accelerate Diagnostics, Inc. 0.034
ETFs With Exposure to THMO
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 149.9
VXF Vanguard Extended Market Index Fund 0 212.13
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 161.96
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 161.98
VEMPX Vanguard Extended Market Index InstlPlus 0 399.7
Unlock